These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8207931)

  • 21. Numerical analysis of an immunochromatographic test strip reader in abused drugs screening.
    Chang YZ; Yao WF; Hsiung KP; Chiou MS; Li HY
    J Immunoassay Immunochem; 2012; 33(2):180-94. PubMed ID: 22471608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of immunoassays in screening for opiates, cannabinoids and amphetamines in post-mortem blood.
    Hino Y; Ojanperä I; Rasanen I; Vuori E
    Forensic Sci Int; 2003 Jan; 131(2-3):148-55. PubMed ID: 12590054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An online immunoassay for LSD: comparison with GC-MS and the Abuscreen RIA.
    McNally AJ; Goc-Szkutnicka K; Li Z; Pilcher I; Polakowski S; Salamone SJ
    J Anal Toxicol; 1996 Oct; 20(6):404-8. PubMed ID: 8889676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference by nonsteroidal anti-inflammatory drugs in EMIT and TDx assays for drugs of abuse.
    Joseph R; Dickerson S; Willis R; Frankenfield D; Cone EJ; Smith DR
    J Anal Toxicol; 1995; 19(1):13-7. PubMed ID: 7723297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance evaluation of four on-site drug-testing devices for detection of drugs of abuse in urine.
    Peace MR; Tarnai LD; Poklis A
    J Anal Toxicol; 2000 Oct; 24(7):589-94. PubMed ID: 11043664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adulteration of urine by "Urine Luck".
    Wu AH; Bristol B; Sexton K; Cassella-McLane G; Holtman V; Hill DW
    Clin Chem; 1999 Jul; 45(7):1051-7. PubMed ID: 10388482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance abuse testing of urine by GC/MS in scanning mode evaluated by proficiency studies, TLC/GC, and EMIT.
    Gibb RP; Cockerham H; Goldfogel GA; Lawson GM; Raisys VA
    J Forensic Sci; 1993 Jan; 38(1):124-33. PubMed ID: 8381160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct determination of benzoylecgonine in serum by EMIT d.a.u. cocaine metabolite immunoassay.
    Poklis A; Jortani S; Edinboro LE; Saady JJ
    J Anal Toxicol; 1994; 18(7):419-22. PubMed ID: 7861757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
    Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
    J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of RapiTest with Emit d.a.u. and GC-MS for the analysis of drugs in urine.
    Korte T; Pykäläinen J; Lillsunde P; Seppälä T
    J Anal Toxicol; 1997; 21(1):49-53. PubMed ID: 9013293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Setting cutoff concentrations for immunoassay screening of postmortem blood.
    Collison IB; Spiehler VR; Guluzian S; Sedgwick PR
    J Forensic Sci; 1998 Mar; 43(2):390-4. PubMed ID: 9544549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multiple-site laboratory evaluation of three on-site urinalysis drug-testing devices.
    Crouch DJ; Frank JF; Farrell LJ; Karsch HM; Klaunig JE
    J Anal Toxicol; 1998 Oct; 22(6):493-502. PubMed ID: 9788525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference with testing for lysergic acid diethylamide.
    Ritter D; Cortese CM; Edwards LC; Barr JL; Chung HD; Long C
    Clin Chem; 1997 Apr; 43(4):635-7. PubMed ID: 9105265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunoassay analysis of lysergic acid diethylamide.
    Cody JT; Valtier S
    J Anal Toxicol; 1997 Oct; 21(6):459-64. PubMed ID: 9323526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).
    Smink BE; Mathijssen MP; Lusthof KJ; de Gier JJ; Egberts AC; Uges DR
    J Anal Toxicol; 2006 Sep; 30(7):478-85. PubMed ID: 16959142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of common opiates and heroin metabolites in urine by high-performance liquid chromatography.
    Low AS; Taylor RB
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):225-33. PubMed ID: 7735470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
    Moody DE; Rittenhouse LF; Monti KM
    J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EMIT cannabinoid assay: confirmation by RIA and GC/MS.
    O'Connor JE; Rejent TA
    J Anal Toxicol; 1981; 5(4):168-73. PubMed ID: 7024638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the radioimmunoassay for benzoylecgonine (a cocaine metabolite) in human urine.
    Mulé SJ; Jukofsky D; Kogan M; De Pace A; Verebey K
    Clin Chem; 1977 May; 23(5):796-801. PubMed ID: 322891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism and elimination of aspirin-induced interference in Emit II d.a.u. assays.
    Linder MW; Valdes R
    Clin Chem; 1994 Aug; 40(8):1512-6. PubMed ID: 8044989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.